Impact of amotosalen photochemical pathogen inactivation treatment (intercept blood system (TM)) on the response to transfusion with 6 and 7-day old components

Osselaer, Jean-Claude; Doyen, Chantal; Defoin, Laurence; Vandenbossche, S.; DEBRY, Cécile; Goffaux, M.; Messe, N.; Van, Hooydonk M.; Corash, L. M.; Lin, L.

Impact of amotosalen photochemical pathogen inactivation treatment (intercept blood system (TM)) on the response to transfusion with 6 and 7-day old components

Osselaer, Jean-Claude

;

Doyen, Chantal

;

Defoin, Laurence

;

Vandenbossche, S.

;

Lin, L.

;et.al.

(2008)

Files

No attached file found for this publication.

Details

Authors

Osselaer, Jean-Claude
Author
Doyen, ChantalUCLouvain
Author
Defoin, LaurenceUCLouvain
Author
Vandenbossche, S.UCLouvain
Author
DEBRY, CécileUCLouvain
Author
Goffaux, M.UCLouvain
Author
Messe, N.UCLouvain
Author
Van, Hooydonk M.UCLouvain
Author
Lin, L.
Author

Affiliations

UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Osselaer, J.-C., Doyen, C., Defoin, L., Vandenbossche, S., DEBRY, C., Goffaux, M., Messe, N., Van, H. M., Corash, L. M., & Lin, L. (2008). Impact of amotosalen photochemical pathogen inactivation treatment (intercept blood system (TM)) on the response to transfusion with 6 and 7-day old components. Vox Sanguinis : international journal of transfusion medicine, 95, 291-292. (Original work published 2008)